Patent · US Active

Angiotensin II receptor antagonist for the prevention or treatment of systemic diseases in cats

US9308197B2 · kind B2 · utility

2Cited by

10References

12Claims

0Family size

Assignee

BOEHRINGER INGELHEIM VETMEDICA GMBH · DE

Inventors

Marcus Stark · Ingelheim am Rhein, DE
Ulrike D. Sent · Wiesbaden, DE
Ingo Lang · Ingelheim am Rhein, DE

Key dates

Filing date	Mar 13, 2013
Grant date	Apr 12, 2016
Priority date	—
Expiry date	Jul 28, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A pharmaceutical composition for prophylaxis or treatment of systemic diseases in cats, wherein the composition comprising administration of a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan) to a cat in need of such a treatment.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.